Tim Clinton

#AUA26 @UroOnc session - 3 papers in the past year that influenced my practice: @ClintonTim highlights our @EurUrolFocus paper on the outcomes of rob PC-RPLND for testicular cancer @Hoomandjaladat

WATCH 👀: @ClintonTim of @DanaFarber discusses discusses differences between genders in terms of bladder cancer presentation. See the whole video here ➡️: hubs.li/Q04fNwqd0 #oncology #blcsm

@DrChoueiri @kaydaustin @MichelleDunno17 @DanaFarber @DanaFarber_GU The best!

Congratulations @MichelleDunno17 from all of us @DanaFarber and @DanaFarber_GU for being a role model of the best GU pathologist anyone can wish for ! Richly deserved !

What they don’t teach you in medical training: Your patients will continually inspire you with their courage and compassion Immensely proud of @devonchoi for sharing his story and raising awareness for testicular cancer by running🏃 🌎 2️⃣6️⃣. 2️⃣! blog.dana-farber.org/insight/2026/0… @ClintonTim @TestesCancer @urotoday @_backtableUro @Uromigos @OncBrothers @crisbergerot @DanaFarber @DanaFarber_GU @DrChoueiri @adamkibel_uro

Testicular Cancer Conference Boston 2025 Presented by @FennecPharma was an incredible and truly awe-inspiring experience. On behalf of our entire team at the Testicular Cancer Awareness Foundation, thank you again for being part of this milestone event. Sincere appreciation and gratitude! Honorary Speaker @DrDarrenFeldman Lead Chair @ClintonTim Lindsay Frazier, MD @RichMatulewicz @bergsa83 Pierre Sayad, PhD, MS, Lydia Chevalier, PhD, Christopher Recklitis, PhD, MPH, Martin Kathrins, MD, @KeyanSalari, Dr. Charles Peyton, Keith Hanigan, @Khalid_Alkhatib Dr. Michael Glover, Dr. Peter Reisz, Dr. Todd Yezefski, & TCAF board member Sean Q Kern, MD., @aloktewar Anthony Spina, FNP, Jesse Solomon, T. Clark Gamblin, MD, MS, MBA, @BjComedy @stevencrocker @hrbekroenick Special thanks as well to @MassGenBrigham @DanaFarber @Harvard & @harvardmed for the great collaborative effort. A heartfelt thank-you to our generous sponsors: @FennecPharma, @Natera, @MassGenBrigham, Thompson Philanthropic Trust, Flagstone Foods & Emerald Nuts, and Oddballs Funguy. We’re so proud of what we accomplished together and the meaningful work being done to support patients, survivors, and caregivers while advancing knowledge of the most innovative testing and treatments that enhance quality of life beyond cancer. #testicularcancer #urology #UroSoMe #menshealth #survivorship

We are excited to announce @CarvalhoFilipeL as our 2025 Rising Stars in Urology Research Awardee! His groundbreaking work targets immune cells that hinder bladder cancer treatment, paving the way for more effective, personalized therapies. Read more 👉 bit.ly/47m3Zic

@TestesCancer Boston Annual meeting , @DrDarrenFeldman @MSKCancerCenter taking the stage ! Thanks to @ClintonTim as conference chair @DanaFarber_GU

Are you a testicular cancer patient, survivor, caregiver or tc medical provider? Our 10th annual Testicular Cancer Conference presented by @FennecPharma is soon approaching - register today! Special thanks to @BrighamMass @DanaFarber @Harvard Click link to register today - …sticularcancerawarenessfoundation.org/tc-conference-… #testicularcancer #urology #urosome #medonc

Excited to see our paper in print @EUplatinum: europeanurology.com/article/S0302-… Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial Carcinoma

Dominic Gross: From Fighting Crime to Beating Cancer Welcome to episode 76 In this episode of It Takes Balls, Dominic Gross, an FBI special agent and testicular cancer survivor, shares his journey from diagnosis to recovery. Dominic first noticed something was off while going through intense SWAT training, experiencing pain and swelling that he initially brushed aside. Struggling to find a primary care provider, he eventually secured an appointment, which led to a quick series of tests confirming his diagnosis. His treatment included surgery, chemotherapy, and an RPLND surgery with Dr. Tim Clinton @ClintonTim each presenting its own set of physical and emotional challenges. #testicularcancer #urology #menshealth Link in comments ⬇️

Join us: annual Shelby Webster #testicularcancer conf @MethodistHosp Feb 20-21. Case based mtg, virtual/in person @nabiladra - VP guest speaker. Chris Porter @KKseattle @Testiscancer @ClintCaryMD @AdityaBagrodia @GU_BigWhacks @UroAlsyouf @uroegg @drphil_urology @RHamiltonUrol

primary RPLND in CSIIa/b germ cell tumours+-adjuvant chemotherapy in >300 men, largest cohort published 📊 1/3 had no cancer in removed nodes, cave overtreatment 🎯 Larger marker neg nodes predict teratoma, resection in selected 2b 💉 2 cycles adj chemo after surgery at max

What an incredible evening at our Docs Meet & Greet Social at the 25th Annual Society of Urological Oncology Conference in Dallas, Texas. A total of 48 people gathered including some of the top testicular cancer surgeons in the country, and many other TC medical experts attended this private event hosted by the Testicular Cancer Awareness Foundation and sponsored by @FennecPharma These events help bring together TC medical experts sharing important information with one another as well as learning about all the amazing programs that TCAF has to offer their patients. Together we are making such a positive impactful difference in the fight against testicular cancer. We are incredibly grateful for the continued support of Fennec Pharmaceuticals for events such as this including our annual TC Conferences. Fennec offers the first and only FDA approved hearing loss prevention for adolescence and young adults (AYA) who receive cisplatin chemotherapy to help reduce ototoxicity (hearing loss). Fennec’s hearing loss drug, Pedmark is also recommended by the NCCN guidelines for patients 15-39 years of age. If you are about to start treatment for testicular cancer that includes cisplatin chemotherapy, contact Fennec HEARS at 1-833-7PEDMARK or 1-(833)-773-3627 #testicularcancer #testescancer #testicularcancerawareness #urology #SUO2024 #hearlossprevention #tcsurvivor #patientsupport #patientadvocacy #malecancer #harvard #duke #johnshopkins #ucsdhealth #usc #msk #penn

In today’s episode of It Takes Balls, Dr. Tim Clinton talks about performing minimally invasive retroperitoneal lymph node dissections (RPLND), how robotic RPLND compares to open RPLND, risks involved with both options, how candidates are selected for robotic RPLND, and more! Links in 🧵 #testicularcancer #testiscancer #urology #MensHealth #urosome

⁦@TestesCancer⁩ conference wrap up w/ ask the providers featuring ⁦@ClintonTim⁩ ⁦@DanaFarber⁩ ⁦@BWHUrology⁩ ⁦@IUuro⁩ #Tim Masterson ⁦@KimJonesTCAF⁩ ⁦@BjComedy⁩ and Bocce ball tournament! ⁦@drphil_urology⁩ ⁦⁦@UCSD_Urology⁩

Fantastic conference dedicated to Testicular Cancer. Kicking off with @AdityaBagrodia and @UCSD_Urology as host. @KimJonesTCAF organizing and bringing survivors and experts together! @TestesCancer

@qdtrinh @PittHealthSci @UPMC @MMenonMD @adamkibel_uro @DrChoueiri @DrPaulNguyen @zaracMD @dougsmink @gmdoherty Amazing! Congrats yet again Quoc!

Honored to have been appointed by Dean Shekhar to lead @PittHealthSci @UPMC Department of Urology. Grateful for the guidance and support from mentors and colleagues. @MMenonMD @adamkibel_uro @DrChoueiri @DrPaulNguyen @zaracMD @dougsmink @gmdoherty

Excited to be at #BCANTT24 ! Can’t wait for a great meeting 😍 @DanaFarber_GU @MassGenBrigham

Fantastic work advancing care for our testicular cancer patients by @VinceDAndreaMD future @UrologyMSK superstar! @TestesCancer

Woo!!! Years of hard work in the making. @TheJEADV @SpiessPhilippe @ClintonTim Factors predictive of recurrence, metastasis and death in node‐negative penile squamous cell carcinoma: A retrospective multicentre cohort study onlinelibrary.wiley.com/doi/10.1111/jd…